Reported relationships
Latest disclosed role at each company.
| Company | Last reported as | Report date | Published |
|---|---|---|---|
| OMNICELL, INC.OMCL · Entity 4666 | EVP & Chief Financial Officer | April 01, 2026 | April 03, 2026 |
Disclosed balances
About these balances
Latest available filing per company, not a reconstructed current portfolio. Matching sequences show the last reported balance with all source rows expandable; grouping alone does not establish account ownership. Do not add unresolved positions together. Filings may omit unchanged positions, and amendments may correct only part of an older disclosure. Jointly reported shares are not necessarily this owner's personal holdings.
OMNICELL, INC.
Report date April 01, 2026 · Filed April 03, 2026
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Common StockSEC Table I · non-derivative | Direct | 69,969 |
Reported balance
After 2026-04-01 transaction · row 1
1 source rowRow 1 · 2026-04-01 · Grant · Acquired 37,037 · Balance 69,969 F1: Represents Restricted Stock Units ("RSUs") granted in connection with the Issuer's equity incentive plan. One-third of the RSUs subject to the grant will vest on the first anniversary of the grant date; the remaining two-thirds of the RSUs subject to the grant will vest in equal installments on each of the second and third anniversary of the grant date. |
Filing footnotes · ownership attribution and instrument terms
F1: Represents Restricted Stock Units ("RSUs") granted in connection with the Issuer's equity incentive plan. One-third of the RSUs subject to the grant will vest on the first anniversary of the grant date; the remaining two-thirds of the RSUs subject to the grant will vest in equal installments on each of the second and third anniversary of the grant date.
Past disclosures · reporting ended (1)
No longer tracked through insider filings. These historical balances do not imply present ownership or a zero position.
Allakos Inc.
Report date May 15, 2025 · Filed May 15, 2025
Section 16 reporting ended · disclosed 2025-05-15. Current position is not established by this disclosure.
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Common StockSEC Table I · non-derivative | Direct | 0 |
Reported balance
After 2025-05-15 transaction · row 1
1 source rowRow 1 · 2025-05-15 · Disposition to issuer · Disposed 163,426 · Balance 0 F1: Includes 128,339 shares represented by restricted stock units ("RSUs"). Each RSU represents the Reporting Person's right to receive one share of Common Stock of the Issuer. F2: Disposed of pursuant to the terms of that certain Agreement and Plan of Merger, dated April 1, 2025, by and among the Issuer, Concentra Biosciences, LLC and Concentra Merger Sub III, Inc. (the "Merger Agreement") in exchange for $0.33 in cash per share. |
| Stock Option (right to buy)SEC Table II · derivative / convertible security · Conversion / exercise price $105.16 · Expires 2031-04-19 | Direct | 0 |
Reported balance
After 2025-05-15 transaction · row 2
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 2 · 2025-05-15 · Disposition to issuer · Disposed 27,600 · Balance 0 F3: This option was cancelled without consideration pursuant to the terms of the Merger Agreement. |
| Stock Option (right to buy)SEC Table II · derivative / convertible security · Conversion / exercise price $7.20 · Expires 2033-01-06 | Direct | 0 |
Reported balance
After 2025-05-15 transaction · row 3
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 3 · 2025-05-15 · Disposition to issuer · Disposed 194,144 · Balance 0 F3: This option was cancelled without consideration pursuant to the terms of the Merger Agreement. |
Filing footnotes · ownership attribution and instrument terms
F1: Includes 128,339 shares represented by restricted stock units ("RSUs"). Each RSU represents the Reporting Person's right to receive one share of Common Stock of the Issuer.
F2: Disposed of pursuant to the terms of that certain Agreement and Plan of Merger, dated April 1, 2025, by and among the Issuer, Concentra Biosciences, LLC and Concentra Merger Sub III, Inc. (the "Merger Agreement") in exchange for $0.33 in cash per share.
F3: This option was cancelled without consideration pursuant to the terms of the Merger Agreement.
Transaction history
JSON APIPurchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Company | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| April 01, 2026 Filed Apr 3, 2026 20:05 UTC | OMNICELL, INC. OMCL · Entity 4666 | GrantCommon Stock | 37,037 | $0.00 | $0.00 |
DisclosureSEC source: 0001398311-26-000002 · form4-04032026_040410.xml · nonDerivative · entry 1 Radford Harlan Baird · CIK 0001398311 · EVP & Chief Financial Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 69,969 F1 · shares: Represents Restricted Stock Units ("RSUs") granted in connection with the Issuer's equity incentive plan. One-third of the RSUs subject to the grant will vest on the first anniversary of the grant date; the remaining two-thirds of the RSUs subject to the grant will vest in equal installments on each of the second and third anniversary of the grant date. Read SEC document |
| November 15, 2025 Filed Nov 18, 2025 21:18 UTC | OMNICELL, INC. OMCL · Entity 4666 | GrantCommon Stock | 32,932 | $0.00 | $0.00 |
DisclosureSEC source: 0001398311-25-000004 · form4-11182025_091117.xml · nonDerivative · entry 1 Radford Harlan Baird · CIK 0001398311 · EVP & Chief Financial Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 32,932 F1 · shares: Restricted Stock Units granted in connection with the Issuer's equity incentive plan. One-fourth (25%) of the shares subject to the grant shall vest on November 15, 2026. The remaining three-fourths (75%) of the shares subject to the grant shall vest quarterly over three years on: (i) 2/15; (ii) 05/15; (iii) 8/15; and (iv) 11/15. Read SEC document |
| May 15, 2025 Filed May 15, 2025 20:05 UTC | Allakos Inc. ALLK · Entity 79644 | Disposition to issuerStock Option (right to buy) · Derivative | 194,144 | $0.00 Strike: $7.20 | $0.00 |
DisclosureSEC source: 0001104659-25-049408 · tm2514731-6_4seq1.xml · derivative · entry 3 Radford Harlan Baird · CIK 0001398311 · Chief Financial Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 194,144 shares Expires 2033-01-06 F3 · derivative.exercise_date: This option was cancelled without consideration pursuant to the terms of the Merger Agreement. Read SEC document |
| May 15, 2025 Filed May 15, 2025 20:05 UTC | Allakos Inc. ALLK · Entity 79644 | Disposition to issuerStock Option (right to buy) · Derivative | 27,600 | $0.00 Strike: $105.16 | $0.00 |
DisclosureSEC source: 0001104659-25-049408 · tm2514731-6_4seq1.xml · derivative · entry 2 Radford Harlan Baird · CIK 0001398311 · Chief Financial Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 27,600 shares Expires 2031-04-19 F3 · derivative.exercise_date: This option was cancelled without consideration pursuant to the terms of the Merger Agreement. Read SEC document |
| May 15, 2025 Filed May 15, 2025 20:05 UTC | Allakos Inc. ALLK · Entity 79644 | Disposition to issuerCommon Stock | 163,426 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001104659-25-049408 · tm2514731-6_4seq1.xml · nonDerivative · entry 1 Radford Harlan Baird · CIK 0001398311 · Chief Financial Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 0 F1 · shares: Includes 128,339 shares represented by restricted stock units ("RSUs"). Each RSU represents the Reporting Person's right to receive one share of Common Stock of the Issuer. F2 · price: Disposed of pursuant to the terms of that certain Agreement and Plan of Merger, dated April 1, 2025, by and among the Issuer, Concentra Biosciences, LLC and Concentra Merger Sub III, Inc. (the "Merger Agreement") in exchange for $0.33 in cash per share. Read SEC document |
| March 05, 2025 Filed Mar 7, 2025 22:00 UTC | Allakos Inc. ALLK · Entity 79644 | Tax withholdingCommon Stock | 14,161 | $0.26 | $3,681.86 |
DisclosureSEC source: 0000950170-25-035648 · ownership.xml · nonDerivative · entry 1 Radford Harlan Baird · CIK 0001398311 · Chief Financial Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 163,426 F1 · shares: Shares sold to satisfy the tax withholding obligations by the Reporting Person in connection with the vesting of RSUs. Read SEC document |
| December 06, 2024 Filed Dec 9, 2024 23:30 UTC | Allakos Inc. ALLK · Entity 79644 | Tax withholdingCommon Stock | 13,138 | $1.10 | $14,451.80 |
DisclosureSEC source: 0000950170-24-134676 · ownership.xml · nonDerivative · entry 1 Radford Harlan Baird · CIK 0001398311 · Chief Financial Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 177,587 F1 · shares: Shares sold to satisfy the tax withholding obligations by the Reporting Person in connection with the vesting of RSUs. Read SEC document |
| September 06, 2024 Filed Sep 10, 2024 21:00 UTC | Allakos Inc. ALLK · Entity 79644 | Tax withholdingCommon Stock | 13,665 | $0.65 | $8,882.25 |
DisclosureSEC source: 0000950170-24-105208 · ownership.xml · nonDerivative · entry 1 Radford Harlan Baird · CIK 0001398311 · Chief Financial Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 190,725 F1 · shares: Shares sold to satisfy the tax withholding obligations by the Reporting Person in connection with the vesting of RSUs. Read SEC document |
| June 28, 2024 Filed Jul 2, 2024 21:00 UTC | Allakos Inc. ALLK · Entity 79644 | SaleCommon Stock | 87,064 | $1.01 | $87,934.64 |
DisclosureSEC source: 0000950170-24-080645 · ownership.xml · nonDerivative · entry 1 Radford Harlan Baird · CIK 0001398311 · Chief Financial Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 204,390 F1 · price: This transaction was executed in multiple trades at prices ranging from $0.94 to $1.06 per share. The sale price reported represents the weighted average sale price. Upon request by the Commission staff, the Issuer, or a security holder of the Issuer, the Reporting Person hereby undertakes to provide full information regarding the number of shares sold at each separate price. Read SEC document |
| June 04, 2024 Filed Jun 6, 2024 20:05 UTC | Allakos Inc. ALLK · Entity 79644 | Tax withholdingCommon Stock | 14,565 | $1.19 | $17,332.35 |
DisclosureSEC source: 0000950170-24-069863 · ownership.xml · nonDerivative · entry 1 Radford Harlan Baird · CIK 0001398311 · Chief Financial Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 291,454 F1 · shares: Shares sold to satisfy the tax withholding obligations by the Reporting Person in connection with the vesting of RSUs. Read SEC document |
| March 06, 2024 Filed Mar 7, 2024 22:00 UTC | Allakos Inc. ALLK · Entity 79644 | Tax withholdingCommon Stock | 32,142 | $1.35 | $43,391.70 |
DisclosureSEC source: 0000950170-24-028122 · ownership.xml · nonDerivative · entry 1 Radford Harlan Baird · CIK 0001398311 · Chief Financial Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 306,019 F1 · shares: Shares sold to satisfy the tax withholding obligations by the Reporting Person in connection with the vesting of RSUs. Read SEC document |
| February 16, 2024 Filed Feb 21, 2024 22:00 UTC | Allakos Inc. ALLK · Entity 79644 | GrantStock Option (Right to buy) · Derivative | 900,000 | $0.00 Strike: $1.25 | $0.00 |
DisclosureSEC source: 0001209191-24-003677 · doc4.xml · derivative · entry 1 Radford Harlan Baird · CIK 0001398311 · Chief Financial Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 900,000 Underlying: Common Stock · 900,000 shares Expires 2034-02-16 F1 · derivative.exercise_date: The option was granted on February 16, 2024. The option vests as to one-fourth of the shares on February 16, 2025, and one forty-eighth of the shares vest each month thereafter, subject to the Reporting Person continuing as a service provider through each such date. Read SEC document |
| December 04, 2023 Filed Dec 5, 2023 23:00 UTC | Allakos Inc. ALLK · Entity 79644 | Tax withholdingCommon Stock | 8,380 | $2.50 | $20,950.00 |
DisclosureSEC source: 0001209191-23-057531 · doc4.xml · nonDerivative · entry 1 Radford Harlan Baird · CIK 0001398311 · Chief Financial Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 338,161 F1 · shares: Shares sold to satisfy the tax withholding obligations by the Reporting Person in connection with the vesting of RSUs. Read SEC document |
| September 05, 2023 Filed Sep 7, 2023 20:30 UTC | Allakos Inc. ALLK · Entity 79644 | Tax withholdingCommon Stock | 9,511 | $3.01 | $28,628.11 |
DisclosureSEC source: 0001209191-23-048627 · doc4.xml · nonDerivative · entry 1 Radford Harlan Baird · CIK 0001398311 · Chief Financial Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 346,541 F1 · shares: Shares sold to satisfy the tax withholding obligations by the Reporting Person in connection with the vesting of RSUs. Read SEC document |
| June 02, 2023 Filed Jun 5, 2023 20:05 UTC | Allakos Inc. ALLK · Entity 79644 | Tax withholdingCommon Stock | 8,942 | $5.13 | $45,872.46 |
DisclosureSEC source: 0001209191-23-034258 · doc4.xml · nonDerivative · entry 1 Radford Harlan Baird · CIK 0001398311 · Chief Financial Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 356,052 F1 · shares: Shares sold to satisfy the tax withholding obligations by the Reporting Person in connection with the vesting of RSUs. Read SEC document |
| March 03, 2023 Filed Mar 6, 2023 23:30 UTC | Allakos Inc. ALLK · Entity 79644 | Tax withholdingCommon Stock | 33,907 | $5.75 | $194,965.25 |
DisclosureSEC source: 0001209191-23-016467 · doc4.xml · nonDerivative · entry 1 Radford Harlan Baird · CIK 0001398311 · Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 364,994 F1 · shares: Shares sold to satisfy the tax withholding obligations by the Reporting Person in connection with the vesting of RSUs. Read SEC document |
| January 06, 2023 Filed Jan 9, 2023 23:15 UTC | Allakos Inc. ALLK · Entity 79644 | GrantStock Option (Right to buy) · Derivative | 194,144 | $0.00 Strike: $7.20 | $0.00 |
DisclosureSEC source: 0001209191-23-002621 · doc4.xml · derivative · entry 2 Radford Harlan Baird · CIK 0001398311 · Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 194,144 Underlying: Common Stock · 194,144 shares Expires 2033-01-06 F3 · derivative.exercise_date: The option was granted on January 6, 2023. The option vests as to one-fourth of the shares on January 6, 2024, and one forty-eighth of the shares subject to the option vest each month thereafter, subject to the Reporting Person continuing as a service provider through each such date. Read SEC document |
| January 06, 2023 Filed Jan 9, 2023 23:15 UTC | Allakos Inc. ALLK · Entity 79644 | GrantCommon Stock | 126,640 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-23-002621 · doc4.xml · nonDerivative · entry 1 Radford Harlan Baird · CIK 0001398311 · Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 398,901 F1 · shares: Mr. Radford was awarded 126,640 restricted stock units ("RSUs") pursuant to the Company's 2018 Equity Incentive Plan on January 6, 2023, of which, 25% will vest on March 1, 2024, and the remainder of the RSUs will vest in 12 equal installments on each three month anniversary thereafter, subject to the Reporting Person continuing as a service provider through each such date. F2 · price: Each RSU represents a contingent right to receive one share of Common Stock of the Issuer. Read SEC document |
| December 02, 2022 Filed Dec 5, 2022 23:37 UTC | Allakos Inc. ALLK · Entity 79644 | Tax withholdingCommon Stock | 3,843 | $8.11 | $31,166.73 |
DisclosureSEC source: 0001209191-22-059845 · doc4.xml · nonDerivative · entry 1 Radford Harlan Baird · CIK 0001398311 · Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 272,261 F1 · shares: Shares sold to satisfy the tax withholding obligations by the Reporting Person in connection with the vesting of RSUs. Read SEC document |
| September 02, 2022 Filed Sep 6, 2022 21:05 UTC | Allakos Inc. ALLK · Entity 79644 | Tax withholdingCommon Stock | 585 | $4.54 | $2,655.90 |
DisclosureSEC source: 0001209191-22-048796 · doc4.xml · nonDerivative · entry 1 Radford Harlan Baird · CIK 0001398311 · Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 276,104 F1 · shares: Shares withheld to satisfy the tax obligations by the Reporting Person in connection with the vesting of RSUs. Read SEC document |
| June 02, 2022 Filed Jun 3, 2022 23:00 UTC | Allakos Inc. ALLK · Entity 79644 | Tax withholdingCommon Stock | 2,274 | $2.75 | $6,253.50 |
DisclosureSEC source: 0001209191-22-034347 · doc4.xml · nonDerivative · entry 1 Radford Harlan Baird · CIK 0001398311 · Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 276,689 F1 · shares: Shares withheld to satisfy the tax obligations by the Reporting Person in connection with the vesting of RSUs. Read SEC document |
| February 25, 2022 Filed Mar 1, 2022 22:01 UTC | Allakos Inc. ALLK · Entity 79644 | GrantCommon Stock | 237,608 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-22-014105 · doc4.xml · nonDerivative · entry 1 Radford Harlan Baird · CIK 0001398311 · Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 278,963 F1 · shares: Mr. Radford was awarded 237,608 restricted stock units ("RSUs") pursuant to the Company's 2018 Equity Incentive Plan on February 25, 2022, of which, 25% will vest on March 1, 2023, and the remainder of the RSUs will vest in 12 equal installments on each three month anniversary thereafter, subject to Mr. Radford continuing as a Service Provider through each such date. F2 · price: Each RSU represents a contingent right to receive one share of Common Stock of the Issuer. Read SEC document |
| December 01, 2021 Filed Dec 3, 2021 21:10 UTC | Allakos Inc. ALLK · Entity 79644 | GrantCommon Stock | 24,255 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-21-067803 · doc4.xml · nonDerivative · entry 1 Radford Harlan Baird · CIK 0001398311 · Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 41,355 F1 · shares: Mr. Radford was awarded 24,255 restricted stock units ("RSUs") pursuant to the Company's 2018 Equity Incentive Plan on December 1, 2021, of which, 25% will vest on December 1, 2022, and the remainder of the RSUs will vest in 12 equal installments on each three month anniversary thereafter, subject to Mr. Radford continuing as a Service Provider through each such date. F2 · price: Each RSU represents a contingent right to receive one share of Common Stock of the Issuer. Read SEC document |
| April 19, 2021 Filed Apr 22, 2021 00:05 UTC | Allakos Inc. ALLK · Entity 79644 | GrantStock Option (Right to buy) · Derivative | 27,600 | $0.00 Strike: $105.16 | $0.00 |
DisclosureSEC source: 0001209191-21-027879 · doc4.xml · derivative · entry 2 Radford Harlan Baird · CIK 0001398311 · Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 27,600 Underlying: Common Stock · 27,600 shares Expires 2031-04-19 F2 · derivative.exercise_date: The option vests as to one-fourth of the shares on April 19, 2022, and one forty-eighth of the shares subject to the option vest each month thereafter, subject to the Reporting Person continuing as a service provider through each such date. Read SEC document |
| April 19, 2021 Filed Apr 22, 2021 00:05 UTC | Allakos Inc. ALLK · Entity 79644 | GrantCommon Stock | 17,100 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-21-027879 · doc4.xml · nonDerivative · entry 1 Radford Harlan Baird · CIK 0001398311 · Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 17,100 F1 · shares: Mr. Radford was awarded 17,100 restricted stock units ("RSUs") pursuant to the Company's 2018 Equity Incentive Plan on April 19, 2021, of which, 25% will vest on June 1, 2022, and the remainder of the RSUs will vest in 12 equal installments on each three month anniversary thereafter, subject to Mr. Radford's continued services to the Company through each vesting date. Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.